Healthequity Inc (HQY) EVP Gary D. Robinson Sells 197 Shares

Healthequity Inc (NASDAQ:HQY) EVP Gary D. Robinson sold 197 shares of the stock in a transaction on Monday, April 2nd. The shares were sold at an average price of $60.52, for a total value of $11,922.44. Following the sale, the executive vice president now owns 2,990 shares in the company, valued at $180,954.80. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink.

HQY stock opened at $62.82 on Friday. The firm has a market capitalization of $3,877.77, a PE ratio of 116.33, a PEG ratio of 2.55 and a beta of 1.39. Healthequity Inc has a 1 year low of $40.21 and a 1 year high of $68.75.

How to Become a New Pot Stock Millionaire

Healthequity (NASDAQ:HQY) last released its quarterly earnings results on Monday, March 19th. The company reported $0.06 earnings per share (EPS) for the quarter, hitting the Zacks’ consensus estimate of $0.06. The firm had revenue of $60.44 million for the quarter, compared to the consensus estimate of $58.46 million. Healthequity had a return on equity of 13.47% and a net margin of 20.64%. research analysts predict that Healthequity Inc will post 0.77 earnings per share for the current year.

Several analysts have commented on the company. Zacks Investment Research upgraded Healthequity from a “hold” rating to a “buy” rating and set a $71.00 target price on the stock in a research note on Tuesday, March 27th. Cantor Fitzgerald reiterated a “buy” rating and set a $65.00 target price on shares of Healthequity in a research note on Friday, March 23rd. KeyCorp increased their target price on Healthequity from $66.00 to $72.00 and gave the company an “overweight” rating in a research note on Thursday. Oppenheimer increased their target price on Healthequity from $58.00 to $68.00 and gave the company an “outperform” rating in a research note on Tuesday, March 20th. Finally, Barrington Research increased their target price on Healthequity to $65.00 and gave the company an “outperform” rating in a research note on Tuesday, March 20th. Two research analysts have rated the stock with a hold rating, nine have given a buy rating and one has issued a strong buy rating to the stock. Healthequity currently has an average rating of “Buy” and a consensus price target of $66.50.

Several hedge funds have recently added to or reduced their stakes in the company. BlackRock Inc. boosted its stake in shares of Healthequity by 3.8% in the 4th quarter. BlackRock Inc. now owns 6,751,491 shares of the company’s stock worth $315,026,000 after buying an additional 244,819 shares during the last quarter. Eagle Asset Management Inc. boosted its stake in shares of Healthequity by 58.6% in the 4th quarter. Eagle Asset Management Inc. now owns 1,136,645 shares of the company’s stock worth $53,206,000 after buying an additional 419,914 shares during the last quarter. Wells Fargo & Company MN boosted its stake in shares of Healthequity by 49.5% in the 3rd quarter. Wells Fargo & Company MN now owns 1,108,410 shares of the company’s stock worth $56,063,000 after buying an additional 366,925 shares during the last quarter. Victory Capital Management Inc. boosted its stake in shares of Healthequity by 116.4% in the 4th quarter. Victory Capital Management Inc. now owns 1,031,711 shares of the company’s stock worth $48,139,000 after buying an additional 555,027 shares during the last quarter. Finally, JPMorgan Chase & Co. boosted its stake in shares of Healthequity by 3.2% in the 3rd quarter. JPMorgan Chase & Co. now owns 992,819 shares of the company’s stock worth $49,422,000 after buying an additional 31,147 shares during the last quarter. Hedge funds and other institutional investors own 99.38% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This piece was originally posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this piece on another domain, it was illegally stolen and republished in violation of United States & international trademark and copyright legislation. The correct version of this piece can be accessed at https://www.dispatchtribunal.com/2018/04/07/healthequity-inc-hqy-evp-gary-d-robinson-sells-197-shares.html.

About Healthequity

HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.

Insider Buying and Selling by Quarter for Healthequity (NASDAQ:HQY)

Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply